Personnel Authorized to Implement the Medical Directive
 All staff, following appropriate orientation, must demonstrate the knowledge, skill and judgement required to apply the medical directive o RN hired in the ED o RN on the Float Team who have received training/orientation and are working in the ED o RRT working in the ED
Patient Population and Indications
 Alert and oriented  Aged 1 to 17 years  History of asthma with the use of bronchodilator(s) for prior exacerbations  Triage PRAM (Pediatric Respiratory Assessment Measure) score of 4 to 11.
6. Contraindications  PRAM score < 4  CTAS (Canadian Triage and Acuity Score) 1 or PRAM = 12  Any use of oral corticosteroid in the past 14 days -DISCUSS WITH MD FIRST  Three prior courses of oral steroids in the past year -DISCUSS WITH MD FIRST  Hypersensitivity to prednisone, prednisolone, dexamethasone or oral corticosteroids  Patients meeting any exclusion criteria from the asthma critical pathway  Patients with respiratory condition such as bronchopulmonary dysplasia and cystic fibrosis  Patients with cardiac, metabolic, immunological disease, or history of adrenal suppression  Patients with co-existing acute illness such as pneumonia, pertussis, or croup  Exposure to varicella in the previous 3 weeks in a susceptible child. Interim Revision -November 2017 7. Description of the Procedure a) Identify ED patients with breathing difficulty and a history of asthma, as per the Asthma critical pathway inclusion/exclusion criteria b) Complete a respiratory assessment using PRAM (see below) and baseline vital signs, and document within the appropriate sections of the patients health record. c) Weigh the patient and document d) Determine the appropriate CTAS and treatment regimen based on the patient's PRAM  PRAM score 1 -3: patient will be managed per the initial bronchodilator medical directive only  PRAM score 4 -11: patient will be managed per the initial bronchodilator medical directive and receive one dose of oral steroid, as per the dosing in the table below. This will be given as prednisone tablets, dexamethasone elixir, elixir, prednisolone suspension, or prednisone suspension (depending on drug availability) immediately following the first bronchodilator treatment and before the second dose of the initial three back to back bronchodilator treatments.
(Specifically, the patient will receive the 1st inhaled treatment, then oral psteroid, then the 2 nd inhaled treatment, and then their 3 rd inhaled treatment).  PRAM score 12: notify physician immediately for consideration of IV corticosteroid e) Any questions regarding the appropriateness or dosage of prednisone/prednisolone/ dexamethasone should be discussed with the physician prior to administration. f) When an RN and RRT are working together to provide care for the patient, they must verbally communicate the assessment, plan and medications administered with each other, in addition to documenting within the electronic medication administration record (eMAR). g) If at any time the patient no longer responds appropriately to treatment or deteriorates, immediately notify the physician. 2 mg / kg to a maximum of 50 mg (round up to the nearest 1 mg)
PEDIATRIC RESPIRATORY ASSESSMENT MEASURE (PRAM)

Consent and Documentation
 Verbal consent will be obtained from the patient/parent prior to administration of the medication. Any refusal of treatment will be documented. Documentation of the medication, indicating "as per medical directive #2022", will be made in the patient's health record, as appropriate 9. Quality Management Process  All RNs and RRTs will be educated about the purpose, indications and contraindications, and possible complications for administration of oral prednisone/prednisolone/dexamethasone by the clinical educator or delegate.  All safety reports related to the administration of oral prednisone/prednisolone under this medical directive will be reviewed by the clinical manager, director and medical director. A copy will be forwarded to the Chair of the Medical Directives Committee.  Prior to renewal of this medical directive, audits will be conducted to verify that the medical directive is being used appropriately. 
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